Crescent Biopharma
crescentbiopharma.com
Actively hiring
Oncology Therapeutics
Biologics & Biosimilars
As featured in
View 7 jobs
Claim pageClaim
Follow
Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
How Crescent Biopharma hires
Truth index
A 89/100
Median time to fill
77 days
Ghost roles
0%
Stale roles
25%
Reposted roles
0%
Crescent Biopharma scores A on the Alion truth index (A is best, E worst), measured over 4 open roles re-checked against its own hiring board: 0% look like ghost listings, 25% have gone stale and 0% are the same role posted again. Its roles close in a median of 77 days. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
News
Crescent Biopharma Incorporation Registered Shs Stock Price CBIO Stock Quote, News, and History Markets Insider
The latest Crescent Biopharma Incorporation Registered Shs stock prices, stock quotes, news, and CBIO history to help you invest and trade smarter.
Read more
Report
Report
Certain Warrants of Crescent Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2026.
Read more
Report
Crescent Biopharma Announces Grants of Inducement Awards
WALTHAM, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (
Read more
Report
Exclusive BAC Article: Crescent Biopharma; PD-1 X VEGF CR-001 Data Starting Q1 2027, Combinations Targeting Solid Tumors With ADCs, And Catalysts (NASDAQ:CBIO)
I believe that a good speculative biotech to go over for the Exclusive BAC Subscribers Article would be Crescent Biopharma (CBIO).
Read more
Report
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
ASCEND to evaluate CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor types, including NSCLC and gastrointestinal and gynecological cancers in first-line and previously treated patients Company anticipates reporting proof-of-concept data i
Read more
Report
Crescent Biopharma (CBIO) Price Target Increased by 10.69% to 29.92
The average one-year price target for Crescent Biopharma (NasdaqCM:CBIO) has been revised to $29.92 / share. This is an increase of 10.69% from the prior estimate of $27.03 dated January 11, 2026. The price target is an average of many targets provided by
Read more
Report
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
CR-001 IND cleared by U.S. FDA; Phase 1/2 ASCEND global clinical trial to evaluate CR-001 in first-line and previously treated patients on track to initiate in first quarter of 2026, with proof-of-concept data anticipated in first quarter of 2027 Crescent
Read more
Report
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
--Crescent Biopharma, Inc., a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced regulatory clearances of Investigational New Drug applications for CR-001, a PD-1 x VEGF bisp
Read more
Report
Tech stack
Technologies named in job postings at Crescent Biopharma over the last 12 months, by layer, with the share of postings for each.
Technologies in use
9
Postings analysed
10
Stack modernity
52/100
Cloud & platforms
GCP30%
Sign in to see how your skills match this stack
Sign In
Full Crescent Biopharma tech stack
9 technologies · by team · pay by technology · changes · similar stacks
Salary insights
Compensation ranges based on this company's open jobs
Median
$303k
Typical range
$130k – $365k
Open positions
10
10
Jobs
Senior
30%
Staff
20%
Architect
50%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 3 | $190k | $190k – $285k |
| Staff | 2 | $248k | $130k – $365k |
| Architect | 5 | $323k | $242k – $357k |
Highest paying role
Executive Director/Vice President, Medical Lead
$365k
Normalized to USD per year
All salaries at Crescent Biopharma
By role, level and city, against the market · 10 jobs with pay
Growth
Hiring Momentum
45/100
Stable
Open positions
12
3 opened / 4 closed in 30 days
Median time-to-fill
77 days
faster than 16% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
27% ▲
Biotech
27% ▼
Finance
18% ▼
HR
9% ▲
Operations
9% ▼
Industrial Engineering
9% ▲
Activity Timeline
Added Immunohistochemistry to stack
Oct 2026
Added Veeva to stack
Oct 2026
Added Medidata Rave to stack
Oct 2026
Added LIMS to stack
Oct 2026
Added Good Clinical Practice to stack
Oct 2026
Added GMP to stack
Oct 2026
Added Smartsheet to stack
Oct 2026
Added SharePoint to stack
Oct 2026
Added Microsoft Office to stack
Oct 2026
Added LinkedIn to stack
Oct 2026
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Waltham
Waltham
United States
HQ
Contact
12 open roles 11 posted in 90 days 200-500 est. staff $276k Avg Salary
hires for Early Careers, Biotech, Finance
300 Fifth Avenue, Waltham, MA 02451
Jobs
$260k – $285k per year · In office · Full-Time · 10+ years exp · Bachelor's Degree · Waltham
GMP
LIMS
MedTech
CAPA
Apply
$170k – $190k per year · In office · Full-Time · 5+ years exp · PhD · Waltham
Immunohistochemistry
Apply
≈ $97k – $284k per year (Estimated) · In office · 10+ years exp · Bachelor's Degree · Waltham
Smartsheet
SharePoint
Apply
≈ $103k – $304k per year (Estimated) · In office · 8+ years exp · Bachelor's Degree · Waltham
Good Clinical Practice
LIMS
Medidata Rave
Apply
$323k – $357k per year · In office · Full-Time · 15+ years exp · Waltham
Veeva
Apply
$323k – $357k per year · In office · Full-Time · 12+ years exp · Master's Degree · Waltham
Apply
$290k – $323k per year · In office · Full-Time · 12+ years exp · PhD · Waltham
Apply